截至2023年6月7日，中位随访时间为19.9个月。所有试验参与者都进行了至少1次肿瘤成像评估。试验中的预定访问已全部完成，生存期随访仍在进行中。在103名患者中，55名患者发生了死亡事件，中位OS（mOS）为14.1个月，6个月OS率为85.4%。

American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13 th and 15 th 2025, was host to the Case-Based Session: Management of ...

Chimerism was monitored following AZA treatment in only 15 patients ... In the current report, AZA was not used as first-line salvage therapy in 39% of patients. However, 38% of the patients ...

High prostate-specific antigen levels before High-Intensity Focused Ultrasound were linked to higher recurrence and treatment failure in intermediate-risk prostate cancer.

After re-staging patients, ideally with PSMA-PET, and performing a biopsy to confirm the recurrence and stratify them into risk categories, it is time to discuss local salvage treatment. Options ...

Reports on a new treatment that is giving these men more ... Doctor Schwen said Sedivy was a perfect candidate for the salvage HIFU procedure. “Salvage HIFU is a promising newer option for ...

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission following second-line salvage therapy.